Dorsey Wright & Associates ARWR ARROWHEAD PHARMACEUTICALS IN

Ownership history in Dorsey Wright & Associates  ·  2 quarters on record

AI Ownership Summary

Dorsey Wright & Associates reported ARROWHEAD PHARMACEUTICALS IN (ARWR) in 2 quarterly 13F filings from 2026 Q2 through 2026 Q2. Peak portfolio weight reached 1.35% in 2026 Q2. The latest visible filing shows ARWR at 1.35% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ARWR ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Dorsey Wright & Associates's position in ARROWHEAD PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

ARWR was reported at 1.35% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.35% in 2026 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2026 Q2 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Dorsey Wright & Associates held ARWR — position size vs. price
% of Fund (quarterly)    ARWR price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 1 quarter  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED 97,466 +95,771 +5650.2% 1.35% $7.9M 2026-08-06 $85.83
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Dorsey Wright & Associates and ARWR

These are the practical questions this page is built to answer before you even open the full history table.

How long has Dorsey Wright & Associates reported owning ARWR?

Dorsey Wright & Associates reported ARWR across 1 quarterly 13F filings, from 2026 Q2 through 2026 Q2.

What was the largest reported ARWR position in Dorsey Wright & Associates's portfolio?

The largest reported portfolio weight for ARWR was 1.35% in 2026 Q2.

What is the latest reported ARWR position on this page?

The most recent filing on this page is 2026 Q2, when Dorsey Wright & Associates reported 97,466 shares, equal to 1.35% of portfolio, with an estimated market value of $7.9M.

What does the chart on this ARWR ownership page compare?

The chart compares Dorsey Wright & Associates's quarterly ARWR portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Dorsey Wright & Associates Holdings